+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Drugs By Therapeutic Area Market Research Reports

Hepatitis Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Hepatitis Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
Gout Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Gout Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
From
Cannabis Extract - Global Strategic Business Report - Product Thumbnail Image

Cannabis Extract - Global Strategic Business Report

  • Report
  • April 2025
  • 96 Pages
  • Global
From
Hyperlipidemia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hyperlipidemia Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 94 Pages
  • Global
From
Research Antibodies - Global Strategic Business Report - Product Thumbnail Image

Research Antibodies - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Radiodermatitis - Global Strategic Business Report - Product Thumbnail Image

Radiodermatitis - Global Strategic Business Report

  • Report
  • April 2025
  • 93 Pages
  • Global
From
Asthma Therapeutics - Global Strategic Business Report - Product Thumbnail Image

Asthma Therapeutics - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Antifungal Drugs - Global Strategic Business Report - Product Thumbnail Image

Antifungal Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 179 Pages
  • Global
From
Alpha-1 Antitrypsin Drugs - Global Strategic Business Report - Product Thumbnail Image

Alpha-1 Antitrypsin Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Gaucher Disease Treatment - Global Strategic Business Report - Product Thumbnail Image

Gaucher Disease Treatment - Global Strategic Business Report

  • Report
  • April 2025
  • 194 Pages
  • Global
From
Hemophilia Drugs - Global Strategic Business Report - Product Thumbnail Image

Hemophilia Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 182 Pages
  • Global
From
Lifestyle Drugs - Global Strategic Business Report - Product Thumbnail Image

Lifestyle Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 184 Pages
  • Global
From
Infertility Drugs - Global Strategic Business Report - Product Thumbnail Image

Infertility Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
Legal Marijuana - Global Strategic Business Report - Product Thumbnail Image

Legal Marijuana - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
Myasthenia Gravis Drugs - Global Strategic Business Report - Product Thumbnail Image

Myasthenia Gravis Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 182 Pages
  • Global
From
Medical Marijuana - Global Strategic Business Report - Product Thumbnail Image

Medical Marijuana - Global Strategic Business Report

  • Report
  • April 2025
  • 193 Pages
  • Global
From
From
Peptic Ulcer Drugs - Global Strategic Business Report - Product Thumbnail Image

Peptic Ulcer Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 196 Pages
  • Global
From
Nocturia Drugs - Global Strategic Business Report - Product Thumbnail Image

Nocturia Drugs - Global Strategic Business Report

  • Report
  • April 2025
  • 192 Pages
  • Global
From
Loading Indicator

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more